Press releaseGlobe Newswire
Rapid Micro Biosystems
RPID · NASDAQ
$0.7717−$0.0019 (−0.25%)TodayMarket closed ·
Prev close $0.7736
Latest news
- Press releaseGlobe Newswire
Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results
- Press releaseGlobe Newswire
Rapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten Offering
- News
Rapid Micro Biosystems Q1 2026 Earnings Call: Complete Transcript
- Press releaseGlobe Newswire
Rapid Micro Biosystems Reports First Quarter 2026 Financial Results
- News
Earnings Scheduled For May 13, 2026
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
Earnings Scheduled For March 12, 2026
- Press releaseGlobe Newswire
Rapid Micro Biosystems Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance
- Press releaseGlobe Newswire
Rapid Micro Biosystems Announces Follow-on Multi-System Order from Samsung Biologics to Expand Deployment of Growth Direct® Platform
- Press releaseGlobe Newswire
Rapid Micro Biosystems Announces Record Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue
- News
Earnings Scheduled For November 7, 2025
- Press releaseGlobe Newswire
Rapid Micro Biosystems Reports Third Quarter 2025 Financial Results; Announces Record Multi-System Customer Order and Raises Full-Year Revenue and System Placement Guidance
- News
Earnings Outlook For Rapid Micro Biosystems
- Press releasePRNewswire
Trinity Capital Inc. Provides $45 Million in Growth Capital to Rapid Micro Biosystems, Modernizing Healthcare Industry Practices
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- Press releaseGlobe Newswire
Rapid Micro Biosystems Reports Second Quarter 2025 Financial Results
- News
Earnings Scheduled For August 12, 2025
- News
A Look Ahead: Rapid Micro Biosystems's Earnings Forecast
- News
Rapid Micro Biosystems's Earnings Outlook
- Press releaseGlobe Newswire
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Guidance
- NewsRishabh Mishra
US Stocks Likely To Open Higher Following A Sell-Off, 'This Choppy Start To 2025 Isn't Abnormal. Don't Panic,' Says Expert Highlighting Seasonal Weakness In The First Quarter After Elections
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.